AI Retinal Image Analysisfor Fundus Photography
Fundus image registration, retinal segmentation, and interpretable metrics for clinical and research workflows — backed by world-class research at the University of Edinburgh.
Eye disease is a global,
and growing, problem.
- 589Madults living with diabetes worldwideprojected to rise to 853M by 2050Source: IDF Diabetes Atlas 2025
- 196Mpeople estimated to be living with AMDprojected to reach 288M by 2040Source: Wong et al. via NCBI Bookshelf
- 80Mpeople worldwide living with glaucomaabout half are unaware they have it
Retinal disease is rising while screening and follow-up still rely on slow manual review, so EES helps teams scale retinal analysis with:
- reproducible image registration for accurate longitudinal comparison
- automated anatomical segmentation across key retinal structures
- interpretable metrics that make progression easier to quantify and triage earlier
This gives optometrists, clinicians, and researchers a more scalable workflow without sacrificing rigor.
From Image to Insight
- Step 1
Capture
Retinal fundus images are acquired with standard imaging equipment already used in clinical practice.
- Step 2
Analyse
Our deep-learning models segment vessels, optic disc, fovea, and other key anatomical structures.
- Step 3
Insight
Clinicians access a dashboard with visual overlays, retinal metrics, and structured reports.
Compatible with standard fundus image formats — DICOM, TIFF, PNG, BMP.
Purpose-Built Solutions for Retinal Imaging
Our product suite brings AI-powered analysis into clinical workflows.
FundusLab
Image registration and analysis for fundus photography
FundusLab automates the analysis of fundus images, leveraging deep learning to segment key retinal structures and register longitudinal studies. Designed for optometrists, by retinal researchers — it delivers rapid, interpretable insights to support clinical decision-making and research.
Next product
OCT-grade analytics, in development
We are extending the EES platform to additional imaging modalities. Reach out if you would like to be notified when it ships or to participate in early validation studies.
All EES products are built on the same research-validated AI foundation, with continuous updates as clinical evidence evolves.
Engineered for clinical and research rigor
Every output is designed to be transparent, reproducible, and ready to integrate into existing workflows.
Deep Learning Segmentation
Trained on clinically validated datasets for high sensitivity and specificity across vessels, disc, and fovea.
Rapid Processing
Results are delivered in seconds, integrating seamlessly into existing clinical workflows and research pipelines.
Interpretable Outputs
Explainable AI visualisations — overlays, heatmaps, and metrics — that domain experts can trust and act on.
Research-Grade Accuracy
Developed and validated by University of Edinburgh researchers, grounded in peer-reviewed methodology.
Built by Researchers, for Optometrists
Our team combines deep expertise in retinal imaging, computer vision, and clinical research — with direct experience working alongside ophthalmologists.
Grounded in Peer-Reviewed Science
Our methods are documented in the open scientific literature and continually validated against new data.
Optic Disc Pallor in Parkinson's Disease: A UK Biobank Study
Gibbon S., Breen D. P., MacGillivray T. J.
Arteriole and venule segmentation in infra-red scanning laser ophthalmoscope (IRSLO) images: a novel dataset and deep learning model
Threlfall A., Burke J., Gibbon S., et al.
PallorMetrics: Software for Automatically Quantifying Optic Disc Pallor in Fundus Photographs, and Associations With Peripapillary RNFL Thickness
Gibbon S., Muniz-Terrera G., Yii F., et al.
One platform, many workflows
From front-line clinics to global trials, EES adapts to your imaging pipeline.
Clinics
Integrate AI triage and screening into ophthalmology and optometry departments.
Research Institutions
Accelerate retinal imaging studies with automated, reproducible analysis pipelines.
Pharma & Biotech
Use retinal biomarkers as endpoints in clinical trials and translational programmes.
Ready to see the difference?
Get in touch to request a demo, discuss a research partnership, or learn more about our technology.




